Skip to main content

Peer Review reports

From: A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial

Original Submission
14 Dec 2016 Submitted Original manuscript
5 Mar 2017 Reviewed Reviewer Report - A Habr-Gama
17 May 2017 Author responded Author comments - Nick Battersby
Resubmission - Version 2
17 May 2017 Submitted Manuscript version 2
3 Jul 2017 Editorially accepted
29 Aug 2017 Article published 10.1186/s13063-017-2085-2

You can find further information about peer review here.

Back to article page